Top award for medical device startup, NIMo

07/11/2017 - 15:41

Bookmark

Save articles for future reference.

Medical innovation and commercialisation group SPARK Co-Lab launched its 2017 Design Course Pitch Night last night, naming medical device startup NIMo (Non Invasive Monitoring) as the winner.

NIMo founders Marthe Smith (left), Alex Wu, Robert Pass and Amy Finlay-Jones.

Medical innovation and commercialisation group SPARK Co-Lab launched its 2017 Design Course Pitch Night last night, naming medical device startup NIMo (Non Invasive Monitoring) as the winner.

NIMo was one of six teams to present at Spark Co-Lab’s second annual Pitch Night event, which was presented by Accelerating Australia.

It competed for a prize pool of financial support and professional services to help bring inventions to market, including support from patent attorney Wrays, financial consultant EY and the CERI (Centre for Entrepreneurial Innovation and Research).

NIMo has created of a non-invasive wearable smart-system, IBDConnect, to support self-monitoring in patients with inflammatory bowel disease (IBD).

The device uses wearable technology to detect key biomarkers associated with IBD, and provides early warning signs of disease flares, health status feedback and support via a mobile application.

Spark Co-Lab director and co-founder Katharine Giles said NIMo was a deserving recipient of the Design Course Pitch Night prize.

“Through their efforts, they (NIMo) embody everything that Spark Co-Lab stands for - collaboration, curiosity, and above all a laser focus on finding a solution to real life medical challenges, in this case inspired by the personal experience of one of their own team members,” she said.

Dr Giles said Spark Co-Lab had expanded over the last year, becoming a more integrated part of Spark Global Network and securing $70,000 in funding from the City of Perth to go towards a new course offering, the Actuator Series.

The Actuator Series will be a series of free weekly lectures launched in 2018 that provide medical researchers and early-stage entrepreneurs with support.

“It covers the A-Z of drug and medical device development and the content is given by industry experts,” Dr Giles told Business News.

“It’s targeted at researchers and clinicians who are looking to translate their discoveries.

“The lectures will cover things from how to understand your clinical needs, to information about how to understand the regulatory framework you’d have to go to through to get your drug or device onto the market, to intellectual property protection, to pitching to venture capitalist; so it’s all the steps for how do you take an awesome discovery and get it to the patient at the bedside.”

Dr Giles said co-founder Peter Santa Maria had recently returned to work at Standford in the US but was still very much a part of Perth’s Spark Co-Lab team.

“He got headhunted back to Stanford, they gave him an offer he absolutely couldn’t refuse,” she said.

“He’s heavily involved in both the spark and the bio-design programs over there as well and now we’ve got a hotline into Stanford, which is really useful.”

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options